|
DPY19L3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.798200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.267700E-02 |
| Normal-vs-Stage2 |
3.398400E-02 |
| Normal-vs-Stage3 |
8.409300E-04 |
| Normal-vs-Stage4 |
4.054300E-02 |
| Stage1-vs-Stage2 |
8.978400E-01 |
| Stage1-vs-Stage3 |
6.270200E-01 |
| Stage1-vs-Stage4 |
5.888600E-01 |
| Stage2-vs-Stage3 |
7.261200E-01 |
| Stage2-vs-Stage4 |
6.720600E-01 |
| Stage3-vs-Stage4 |
8.257400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.983600E-03 |
| Normal-vs-AfricanAmerican |
8.44939999966599E-07 |
| Normal-vs-Asian |
1.196620E-04 |
| Caucasian-vs-AfricanAmerican |
2.211800E-01 |
| Caucasian-vs-Asian |
5.645700E-02 |
| AfricanAmerican-vs-Asian |
5.726200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.92000012847416E-10 |
| Normal-vs-Female |
7.824800E-01 |
| Male-vs-Female |
4.172300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.426300E-04 |
| Normal-vs-Extreme_Weight |
1.658620E-01 |
| Normal-vs-Obese |
1.540040E-03 |
| Normal-vs-Extreme_Obese |
1.85459999999527E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.592600E-01 |
| Normal_Weight-vs-Obese |
3.646000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.153800E-01 |
| Extreme_Weight-vs-Obese |
9.006000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.577800E-01 |
| Obese-vs-Extreme_Obese |
1.500960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.440430E-02 |
| Normal-vs-Age(41-60Yrs) |
3.809600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.47189996144459E-09 |
| Normal-vs-Age(81-100Yrs) |
1.72260000042002E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.510800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.184600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.282200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.818000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.528460E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.984000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.09750000385634E-08 |
| Normal-VS-Type2 PRCC |
1.84049999685243E-08 |
| Normal-VS-KIRP CIMP |
1.783630E-01 |
| Normal-VS-Unclassified PRCC |
6.676300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.147400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.080400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.228250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.746780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.143900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.353400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.01290153620948E-11 |
| Normal-vs-N1 |
6.669600E-02 |
| Normal-vs-N2 |
6.036400E-03 |
| N0-vs-N1 |
1.889720E-02 |
| N0-vs-N2 |
6.396800E-01 |
| N1-vs-N2 |
4.511000E-01 |
|
|
